Knoll Capital Management’s Entera Bio ENTX Stock Holding History

Knoll Capital Management’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.47M	Hold	5,881,879	–	–	3.59%	12
2025 Q4	$11.4M	Hold	5,881,879	–	–	5.23%	8
2025 Q3	$11.3M	Hold	5,881,879	–	–	6.05%	4
2025 Q2	$11.2M	Hold	5,881,879	–	–	7.95%	3
2025 Q1	$10M	Hold	5,881,879	–	–	6.5%	3
2024 Q4	$12.5M	Buy	5,881,879 +2,000,000	+52%	+$3.73M	8.03%	3
2024 Q3	$7.38M	Hold	3,881,879	–	–	3.42%	7
2024 Q2	$7.14M	Hold	3,881,879	–	–	4.81%	6
2024 Q1	$6.48M	Hold	3,881,879	–	–	4.03%	6
2023 Q4	$2.33M	Buy	3,881,879 +1,397,604	+56%	+$953K	1.93%	14
2023 Q3	$1.8M	Hold	2,484,275	–	–	1.87%	15
2023 Q2	$2.09M	Hold	2,484,275	–	–	2.54%	9
2023 Q1	$2.88M	Hold	2,484,275	–	–	4.44%	6
2022 Q4	$2.58K	Hold	2,484,275	–	–	0.01%	21
2022 Q3	$2.58M	Hold	2,484,275	–	–	1.51%	3
2022 Q2	$3.3M	Hold	2,484,275	–	–	1.89%	4
2022 Q1	$7.13M	Hold	2,484,275	–	–	4.47%	2
2021 Q4	$6.99M	Hold	2,484,275	–	–	3.84%	3
2021 Q3	$11.7M	Hold	2,484,275	–	–	5.84%	3
2021 Q2	$14.9M	Buy	2,484,275 +692,912	+39%	+$2.56M	7.76%	3
2021 Q1	$6.83M	Buy	1,791,363 +50,000	+3%	+$115K	4.45%	5
2020 Q4	$1.88M	Hold	1,741,363	–	–	1.28%	12
2020 Q3	$2.16M	Hold	1,741,363	–	–	1.77%	11
2020 Q2	$3.01M	Hold	1,741,363	–	–	1.74%	9
2020 Q1	$3.27M	Hold	1,741,363	–	–	3.08%	6
2019 Q4	$3.6M	Buy	1,741,363 +1,265,823	+266%	+$2.9M	2.66%	8
2019 Q3	$1.18M	Hold	475,540	–	–	1.08%	15
2019 Q2	$1.47M	Hold	475,540	–	–	1.21%	15
2019 Q1	$2.06M	Hold	475,540	–	–	1.56%	12
2018 Q4	$1.45M	Hold	475,540	–	–	1.65%	7
2018 Q3	$2.41M	Hold	475,540	–	–	2.03%	8
2018 Q2	$3M	Buy	+475,540	New	+$2.99M	2.55%	7

Other funds holding ENTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SFCM

Seven Fleet Capital Management Mountain View, California $318M AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Knoll Capital Management's ENTX Position: Q1 2026 in Review

Knoll Capital Management held its Entera Bio (ENTX) position steady in Q1 2026 at 5,881,879 shares worth $6.47M. The position accounts for 3.59% of the portfolio, ranked #12.

Knoll Capital Management first reported a position in ENTX in Q2 2018 and has held it in 32 quarters since. The position peaked at $14.9M in Q2 2021. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

Knoll Capital Management held 5,881,879 shares of Entera Bio worth $6.47M as of Q1 2026.
Knoll Capital Management left its Entera Bio share count unchanged in Q1 2026.
Entera Bio made up 3.59% of Knoll Capital Management's portfolio in Q1 2026, its #12 holding.
Knoll Capital Management first reported a position in Entera Bio in Q2 2018 and has held it in 32 quarters since.
Knoll Capital Management's Entera Bio position peaked at $14.9M in Q2 2021.
26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Knoll Capital Management's 13F filing for Q1 2026, filed 15 May 2026.